Bolignano, D <br/><br/>
The Dark Side of Blocking RAS in Diabetic Patients with Incipient or Manifested Nephropathy.  [electronic resource] 

 -  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association  Jun 2016 
 - 350-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1439-3646 
<br/><br/><label>Standard No.: </label>10.1055/s-0035-1550017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin Receptor Antagonists--therapeutic use<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Diabetic Nephropathies--drug therapy<br/>Humans<br/>Receptors, Cell Surface--antagonists & inhibitors<br/>Renin-Angiotensin System--drug effects<br/>Vacuolar Proton-Translocating ATPases--antagonists & inhibitors